ALZCHEM GROUP AG (ACT.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:ACT - DE000A2YNT30 - Common Stock
130.8 EUR
-0.6 (-0.46%)
Overall ACT gets a fundamental rating of 7 out of 10. We evaluated ACT against 74 industry peers in the Chemicals industry. ACT gets an excellent profitability rating and is at the same time showing great financial health properties. ACT has a decent growth rate and is not valued too expensively. This makes ACT very considerable for quality investing!
1. Profitability
1.1 Basic Checks
ACT had positive earnings in the past year.
In the past year ACT had a positive cash flow from operations.
ACT had positive earnings in each of the past 5 years.
ACT had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
ACT's Return On Assets of 10.49% is amongst the best of the industry. ACT outperforms 95.95% of its industry peers.
ACT has a Return On Equity of 26.47%. This is amongst the best in the industry. ACT outperforms 97.30% of its industry peers.
Looking at the Return On Invested Capital, with a value of 13.45%, ACT belongs to the top of the industry, outperforming 94.59% of the companies in the same industry.
ACT had an Average Return On Invested Capital over the past 3 years of 12.06%. This is significantly above the industry average of 6.48%.
The last Return On Invested Capital (13.45%) for ACT is above the 3 year average (12.06%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.49% | ||
| ROE | 26.47% | ||
| ROIC | 13.45% |
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
1.3 Margins
ACT has a better Profit Margin (10.97%) than 86.49% of its industry peers.
In the last couple of years the Profit Margin of ACT has grown nicely.
ACT has a Operating Margin of 15.93%. This is amongst the best in the industry. ACT outperforms 86.49% of its industry peers.
ACT's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 66.55%, ACT belongs to the top of the industry, outperforming 97.30% of the companies in the same industry.
ACT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.93% | ||
| PM (TTM) | 10.97% | ||
| GM | 66.55% |
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
2. Health
2.1 Basic Checks
ACT has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, ACT has less shares outstanding
The number of shares outstanding for ACT has been reduced compared to 5 years ago.
Compared to 1 year ago, ACT has an improved debt to assets ratio.
2.2 Solvency
ACT has an Altman-Z score of 4.64. This indicates that ACT is financially healthy and has little risk of bankruptcy at the moment.
ACT's Altman-Z score of 4.64 is amongst the best of the industry. ACT outperforms 87.84% of its industry peers.
ACT has a debt to FCF ratio of 1.32. This is a very positive value and a sign of high solvency as it would only need 1.32 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.32, ACT belongs to the top of the industry, outperforming 97.30% of the companies in the same industry.
A Debt/Equity ratio of 0.16 indicates that ACT is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.16, ACT is in the better half of the industry, outperforming 72.97% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 1.32 | ||
| Altman-Z | 4.64 |
ROIC/WACC1.9
WACC7.08%
2.3 Liquidity
A Current Ratio of 2.87 indicates that ACT has no problem at all paying its short term obligations.
The Current ratio of ACT (2.87) is better than 83.78% of its industry peers.
A Quick Ratio of 1.77 indicates that ACT should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.77, ACT belongs to the best of the industry, outperforming 81.08% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.87 | ||
| Quick Ratio | 1.77 |
3. Growth
3.1 Past
ACT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.12%, which is quite impressive.
The Earnings Per Share has been growing by 24.60% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 1.05% in the past year.
The Revenue has been growing by 8.06% on average over the past years. This is quite good.
EPS 1Y (TTM)24.12%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%31.66%
Revenue 1Y (TTM)1.05%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%6.46%
3.2 Future
ACT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.26% yearly.
The Revenue is expected to grow by 6.02% on average over the next years.
EPS Next Y18.28%
EPS Next 2Y17.04%
EPS Next 3Y19.49%
EPS Next 5Y20.26%
Revenue Next Year2.83%
Revenue Next 2Y5.94%
Revenue Next 3Y8.48%
Revenue Next 5Y6.02%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 21.44, the valuation of ACT can be described as rather expensive.
ACT's Price/Earnings is on the same level as the industry average.
ACT is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.15, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 18.75, which indicates a rather expensive current valuation of ACT.
ACT's Price/Forward Earnings ratio is in line with the industry average.
ACT is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 36.12, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.44 | ||
| Fwd PE | 18.75 |
4.2 Price Multiples
ACT's Enterprise Value to EBITDA ratio is in line with the industry average.
ACT's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 38.06 | ||
| EV/EBITDA | 11.23 |
4.3 Compensation for Growth
ACT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ACT has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ACT's earnings are expected to grow with 19.49% in the coming years.
PEG (NY)1.17
PEG (5Y)0.87
EPS Next 2Y17.04%
EPS Next 3Y19.49%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.33%, ACT has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.18, ACT is paying slightly less dividend.
With a Dividend Yield of 1.33, ACT pays less dividend than the S&P500 average, which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.33% |
5.2 History
The dividend of ACT has a limited annual growth rate of 6.00%.
Dividend Growth(5Y)6%
Div Incr Years5
Div Non Decr Years5
5.3 Sustainability
49.16% of the earnings are spent on dividend by ACT. This is a bit on the high side, but may be sustainable.
The dividend of ACT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP49.16%
EPS Next 2Y17.04%
EPS Next 3Y19.49%
FRA:ACT (11/28/2025, 11:27:50 AM)
130.8
-0.6 (-0.46%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners35.95%
Inst Owner ChangeN/A
Ins Owners30.48%
Ins Owner ChangeN/A
Market Cap1.33B
Revenue(TTM)563.86M
Net Income(TTM)61.84M
Analysts81.82
Price Target157.34 (20.29%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.33% |
Yearly Dividend1.2
Dividend Growth(5Y)6%
DP49.16%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.59%
PT rev (3m)9.38%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.7%
EPS NY rev (3m)1.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-0.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.44 | ||
| Fwd PE | 18.75 | ||
| P/S | 2.36 | ||
| P/FCF | 38.06 | ||
| P/OCF | 9.15 | ||
| P/B | 5.7 | ||
| P/tB | 5.79 | ||
| EV/EBITDA | 11.23 |
EPS(TTM)6.1
EY4.66%
EPS(NY)6.98
Fwd EY5.33%
FCF(TTM)3.44
FCFY2.63%
OCF(TTM)14.3
OCFY10.93%
SpS55.39
BVpS22.95
TBVpS22.6
PEG (NY)1.17
PEG (5Y)0.87
Graham Number56.13
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.49% | ||
| ROE | 26.47% | ||
| ROCE | 18.66% | ||
| ROIC | 13.45% | ||
| ROICexc | 16.12% | ||
| ROICexgc | 16.26% | ||
| OM | 15.93% | ||
| PM (TTM) | 10.97% | ||
| GM | 66.55% | ||
| FCFM | 6.21% |
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ROICexc(3y)13.35%
ROICexc(5y)11.55%
ROICexgc(3y)13.5%
ROICexgc(5y)11.66%
ROCE(3y)16.73%
ROCE(5y)14.74%
ROICexgc growth 3Y25.57%
ROICexgc growth 5Y18.04%
ROICexc growth 3Y25.41%
ROICexc growth 5Y17.9%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
F-Score6
Asset Turnover0.96
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 1.32 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 125.34% | ||
| Profit Quality | 56.58% | ||
| Current Ratio | 2.87 | ||
| Quick Ratio | 1.77 | ||
| Altman-Z | 4.64 |
F-Score6
WACC7.08%
ROIC/WACC1.9
Cap/Depr(3y)118.98%
Cap/Depr(5y)119.68%
Cap/Sales(3y)5.65%
Cap/Sales(5y)6.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.12%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%31.66%
EPS Next Y18.28%
EPS Next 2Y17.04%
EPS Next 3Y19.49%
EPS Next 5Y20.26%
Revenue 1Y (TTM)1.05%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%6.46%
Revenue Next Year2.83%
Revenue Next 2Y5.94%
Revenue Next 3Y8.48%
Revenue Next 5Y6.02%
EBIT growth 1Y16.7%
EBIT growth 3Y28.68%
EBIT growth 5Y21.47%
EBIT Next Year49.4%
EBIT Next 3Y27.83%
EBIT Next 5Y19.11%
FCF growth 1Y37.23%
FCF growth 3Y62.42%
FCF growth 5Y94.14%
OCF growth 1Y166.77%
OCF growth 3Y34.7%
OCF growth 5Y19.23%
ALZCHEM GROUP AG / ACT.DE FAQ
Can you provide the ChartMill fundamental rating for ALZCHEM GROUP AG?
ChartMill assigns a fundamental rating of 7 / 10 to ACT.DE.
What is the valuation status of ALZCHEM GROUP AG (ACT.DE) stock?
ChartMill assigns a valuation rating of 4 / 10 to ALZCHEM GROUP AG (ACT.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for ALZCHEM GROUP AG?
ALZCHEM GROUP AG (ACT.DE) has a profitability rating of 9 / 10.
What are the PE and PB ratios of ALZCHEM GROUP AG (ACT.DE) stock?
The Price/Earnings (PE) ratio for ALZCHEM GROUP AG (ACT.DE) is 21.44 and the Price/Book (PB) ratio is 5.7.
What is the financial health of ALZCHEM GROUP AG (ACT.DE) stock?
The financial health rating of ALZCHEM GROUP AG (ACT.DE) is 9 / 10.